Rank | Gene Set | Z-score |
---|---|---|
1 | COPI coating of Golgi vesicle (GO:0048205) | 6.14313635 |
2 | Golgi transport vesicle coating (GO:0048200) | 6.14313635 |
3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.96434825 |
4 | protein retention in ER lumen (GO:0006621) | 4.68629680 |
5 | regulation of cholesterol homeostasis (GO:2000188) | 4.13184461 |
6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.07469127 |
7 | L-phenylalanine metabolic process (GO:0006558) | 4.07469127 |
8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.02746024 |
9 | L-phenylalanine catabolic process (GO:0006559) | 4.02746024 |
10 | alpha-linolenic acid metabolic process (GO:0036109) | 4.02662037 |
11 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.88681253 |
12 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.70364239 |
13 | tricarboxylic acid metabolic process (GO:0072350) | 3.66139589 |
14 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.61439655 |
15 | valine metabolic process (GO:0006573) | 3.57963469 |
16 | sulfur amino acid catabolic process (GO:0000098) | 3.54079397 |
17 | positive regulation of nuclease activity (GO:0032075) | 3.48809826 |
18 | COPII vesicle coating (GO:0048208) | 3.42347856 |
19 | pyrimidine nucleoside salvage (GO:0043097) | 3.36680300 |
20 | pyrimidine-containing compound salvage (GO:0008655) | 3.36680300 |
21 | peptide catabolic process (GO:0043171) | 3.35681352 |
22 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.32151439 |
23 | GDP-mannose metabolic process (GO:0019673) | 3.31313243 |
24 | macroautophagy (GO:0016236) | 3.27250092 |
25 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.26706829 |
26 | signal peptide processing (GO:0006465) | 3.23803060 |
27 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.19949884 |
28 | 4-hydroxyproline metabolic process (GO:0019471) | 3.19749296 |
29 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.19424353 |
30 | fatty acid beta-oxidation (GO:0006635) | 3.15194634 |
31 | cellular response to unfolded protein (GO:0034620) | 3.14056058 |
32 | regulation of triglyceride catabolic process (GO:0010896) | 3.10611337 |
33 | opioid receptor signaling pathway (GO:0038003) | 3.09126591 |
34 | regulation of nuclease activity (GO:0032069) | 3.08115834 |
35 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.07887852 |
36 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.07580698 |
37 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.01733134 |
38 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.01733134 |
39 | ER-nucleus signaling pathway (GO:0006984) | 3.00837740 |
40 | 2-oxoglutarate metabolic process (GO:0006103) | 2.99193355 |
41 | apoptotic cell clearance (GO:0043277) | 2.95904704 |
42 | cellular response to topologically incorrect protein (GO:0035967) | 2.95875903 |
43 | oxaloacetate metabolic process (GO:0006107) | 2.95189133 |
44 | drug catabolic process (GO:0042737) | 2.93692476 |
45 | lysine metabolic process (GO:0006553) | 2.93421123 |
46 | lysine catabolic process (GO:0006554) | 2.93421123 |
47 | fatty acid oxidation (GO:0019395) | 2.92022713 |
48 | response to pheromone (GO:0019236) | 2.87873789 |
49 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.87021394 |
50 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.86229049 |
51 | acylglycerol homeostasis (GO:0055090) | 2.85939056 |
52 | triglyceride homeostasis (GO:0070328) | 2.85939056 |
53 | aromatic amino acid family catabolic process (GO:0009074) | 2.84259412 |
54 | sequestering of metal ion (GO:0051238) | 2.83866004 |
55 | lipid oxidation (GO:0034440) | 2.82868873 |
56 | protein carboxylation (GO:0018214) | 2.82609327 |
57 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.82609327 |
58 | fatty acid catabolic process (GO:0009062) | 2.81889281 |
59 | flavonoid metabolic process (GO:0009812) | 2.80763060 |
60 | glyoxylate metabolic process (GO:0046487) | 2.79979249 |
61 | sulfation (GO:0051923) | 2.79091668 |
62 | positive regulation of fatty acid transport (GO:2000193) | 2.76469811 |
63 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.75397289 |
64 | hormone catabolic process (GO:0042447) | 2.75388867 |
65 | protein maturation by protein folding (GO:0022417) | 2.73576105 |
66 | endocrine pancreas development (GO:0031018) | 2.72889483 |
67 | nucleoside salvage (GO:0043174) | 2.70897993 |
68 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.68943281 |
69 | response to misfolded protein (GO:0051788) | 2.68189503 |
70 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.68116189 |
71 | positive regulation of defense response to virus by host (GO:0002230) | 2.67116549 |
72 | regulation of triglyceride metabolic process (GO:0090207) | 2.66616170 |
73 | positive regulation of icosanoid secretion (GO:0032305) | 2.66471769 |
74 | peptide hormone processing (GO:0016486) | 2.65672863 |
75 | transcytosis (GO:0045056) | 2.65412845 |
76 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.64607156 |
77 | auditory receptor cell stereocilium organization (GO:0060088) | 2.64095305 |
78 | positive regulation of protein kinase C signaling (GO:0090037) | 2.63466404 |
79 | glandular epithelial cell development (GO:0002068) | 2.61654953 |
80 | vesicle coating (GO:0006901) | 2.61019416 |
81 | xenobiotic catabolic process (GO:0042178) | 2.60806017 |
82 | detection of molecule of bacterial origin (GO:0032490) | 2.60064865 |
83 | negative regulation of fibrinolysis (GO:0051918) | 2.58308897 |
84 | monocarboxylic acid catabolic process (GO:0072329) | 2.56983161 |
85 | autophagic vacuole fusion (GO:0000046) | 2.56519252 |
86 | exocrine pancreas development (GO:0031017) | 2.56396724 |
87 | cellular response to exogenous dsRNA (GO:0071360) | 2.55742359 |
88 | regulation of cholesterol storage (GO:0010885) | 2.54304901 |
89 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.53725980 |
90 | toxin metabolic process (GO:0009404) | 2.53310869 |
91 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.51576626 |
92 | response to endoplasmic reticulum stress (GO:0034976) | 2.50915642 |
93 | uronic acid metabolic process (GO:0006063) | 2.50598542 |
94 | glucuronate metabolic process (GO:0019585) | 2.50598542 |
95 | drug transmembrane transport (GO:0006855) | 2.50049121 |
96 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.49462145 |
97 | branched-chain amino acid metabolic process (GO:0009081) | 2.48694270 |
98 | drug metabolic process (GO:0017144) | 2.48388035 |
99 | cellular ketone body metabolic process (GO:0046950) | 2.48252801 |
100 | cellular biogenic amine catabolic process (GO:0042402) | 2.47776443 |
101 | amine catabolic process (GO:0009310) | 2.47776443 |
102 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.47259401 |
103 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.47004896 |
104 | intestinal cholesterol absorption (GO:0030299) | 2.46633748 |
105 | lytic vacuole organization (GO:0080171) | 2.46046428 |
106 | lysosome organization (GO:0007040) | 2.46046428 |
107 | negative regulation of digestive system process (GO:0060457) | 2.45383086 |
108 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.43817960 |
109 | mannosylation (GO:0097502) | 2.42105368 |
110 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.41935877 |
111 | NADH metabolic process (GO:0006734) | 2.41722942 |
112 | indolalkylamine catabolic process (GO:0046218) | 2.41368534 |
113 | tryptophan catabolic process (GO:0006569) | 2.41368534 |
114 | indole-containing compound catabolic process (GO:0042436) | 2.41368534 |
115 | cofactor catabolic process (GO:0051187) | 2.40687958 |
116 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.40089929 |
117 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.40089929 |
118 | arginine catabolic process (GO:0006527) | 2.39837102 |
119 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.39684573 |
120 | oxidative demethylation (GO:0070989) | 2.38816868 |
121 | peptidyl-asparagine modification (GO:0018196) | 2.38790120 |
122 | tyrosine metabolic process (GO:0006570) | 2.38431331 |
123 | cysteine metabolic process (GO:0006534) | 2.38033159 |
124 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.37238467 |
125 | glutathione biosynthetic process (GO:0006750) | 2.36929342 |
126 | indolalkylamine metabolic process (GO:0006586) | 2.36276987 |
127 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.35303664 |
128 | regulation of cholesterol metabolic process (GO:0090181) | 2.35082730 |
129 | beta-amyloid metabolic process (GO:0050435) | 2.32680809 |
130 | ketone body metabolic process (GO:1902224) | 2.32677748 |
131 | cellular modified amino acid catabolic process (GO:0042219) | 2.32395756 |
132 | positive regulation of glycolytic process (GO:0045821) | 2.32206789 |
133 | response to unfolded protein (GO:0006986) | 2.32187905 |
134 | bile acid biosynthetic process (GO:0006699) | 2.31219272 |
135 | response to mercury ion (GO:0046689) | 2.30785791 |
136 | nucleotide transmembrane transport (GO:1901679) | 2.30783042 |
137 | amyloid precursor protein catabolic process (GO:0042987) | 2.30745397 |
138 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.30429406 |
139 | exogenous drug catabolic process (GO:0042738) | 2.28246753 |
140 | glandular epithelial cell differentiation (GO:0002067) | 2.27548457 |
141 | short-chain fatty acid metabolic process (GO:0046459) | 2.25515120 |
142 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.23904364 |
143 | NAD biosynthetic process (GO:0009435) | 2.23641963 |
144 | amyloid precursor protein metabolic process (GO:0042982) | 2.21689174 |
145 | epoxygenase P450 pathway (GO:0019373) | 2.21664999 |
146 | L-fucose metabolic process (GO:0042354) | 2.20452941 |
147 | L-fucose catabolic process (GO:0042355) | 2.20452941 |
148 | fucose catabolic process (GO:0019317) | 2.20452941 |
149 | indole-containing compound metabolic process (GO:0042430) | 2.19631981 |
150 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.19572499 |
151 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.19572499 |
152 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.19129486 |
153 | myelin maintenance (GO:0043217) | 2.17714609 |
154 | positive regulation of fatty acid oxidation (GO:0046321) | 2.17658706 |
155 | creatine metabolic process (GO:0006600) | 2.16959555 |
156 | cardiolipin metabolic process (GO:0032048) | 2.16138163 |
157 | female mating behavior (GO:0060180) | 2.15809216 |
158 | negative regulation of cell size (GO:0045792) | 2.15236088 |
159 | tryptophan metabolic process (GO:0006568) | 2.14190319 |
160 | peptide biosynthetic process (GO:0043043) | 2.13433185 |
161 | regulation of defense response to virus by host (GO:0050691) | 2.11223288 |
162 | regulation of sequestering of triglyceride (GO:0010889) | 2.10545430 |
163 | arginine metabolic process (GO:0006525) | 2.10306501 |
164 | fucosylation (GO:0036065) | 2.10163793 |
165 | regulation of memory T cell differentiation (GO:0043380) | 2.08845535 |
166 | proline metabolic process (GO:0006560) | 2.07790591 |
167 | catecholamine transport (GO:0051937) | 2.07601238 |
168 | regulation of female receptivity (GO:0045924) | 2.06660390 |
169 | positive regulation of prostaglandin secretion (GO:0032308) | 2.06212578 |
170 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.05928424 |
171 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.03277476 |
172 | alkaloid metabolic process (GO:0009820) | 2.03003525 |
173 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.01854406 |
174 | plasma membrane fusion (GO:0045026) | 2.00649706 |
175 | organelle membrane fusion (GO:0090174) | 2.00357053 |
176 | glycosylceramide metabolic process (GO:0006677) | 1.98722289 |
177 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 1.98495420 |
178 | nucleoside transmembrane transport (GO:1901642) | 1.97698150 |
179 | neurotransmitter catabolic process (GO:0042135) | 1.97635130 |
180 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 1.97353266 |
181 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 1.96420327 |
182 | cornea development in camera-type eye (GO:0061303) | 1.96235827 |
183 | carbohydrate phosphorylation (GO:0046835) | 1.95499533 |
184 | lipopolysaccharide biosynthetic process (GO:0009103) | 1.95025676 |
185 | regulation of guanylate cyclase activity (GO:0031282) | 1.94726821 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.39129175 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.18697711 |
3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.11807632 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.84058860 |
5 | GATA1_22025678_ChIP-Seq_K562_Human | 3.29192416 |
6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.28323713 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.25900815 |
8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.79892261 |
9 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.68460292 |
10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.56363266 |
11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.52341020 |
12 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.47199552 |
13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.35012115 |
14 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.34405661 |
15 | BCL6_27268052_Chip-Seq_Bcells_Human | 2.27158686 |
16 | P68_20966046_ChIP-Seq_HELA_Human | 2.17564686 |
17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.97032149 |
18 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.91767469 |
19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.90845343 |
20 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.89947982 |
21 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.89685848 |
22 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.89203064 |
23 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.77635022 |
24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.76502779 |
25 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.75669436 |
26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.75125424 |
27 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.74570523 |
28 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.72716012 |
29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.71012430 |
30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.70922474 |
31 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.69610211 |
32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.68054920 |
33 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.67475128 |
34 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.64621247 |
35 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.63170479 |
36 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.61907632 |
37 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.57962891 |
38 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.56203058 |
39 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.52545631 |
40 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.51673564 |
41 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.51426239 |
42 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.51279336 |
43 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.50865255 |
44 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.50487264 |
45 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.47943485 |
46 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.47523513 |
47 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.46847973 |
48 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.46750187 |
49 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.46272410 |
50 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.45450258 |
51 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.43289570 |
52 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.42666838 |
53 | P300_27268052_Chip-Seq_Bcells_Human | 1.39324356 |
54 | SA1_27219007_Chip-Seq_Bcells_Human | 1.37344700 |
55 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.36911948 |
56 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.35193407 |
57 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.35017896 |
58 | ERA_21632823_ChIP-Seq_H3396_Human | 1.34694687 |
59 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.32863360 |
60 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.31418931 |
61 | MYC_22102868_ChIP-Seq_BL_Human | 1.31129539 |
62 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.30849988 |
63 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.29174092 |
64 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.29143015 |
65 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.27650483 |
66 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.27394238 |
67 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.27328832 |
68 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.26803695 |
69 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.26721787 |
70 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.24259151 |
71 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.22917226 |
72 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.22234239 |
73 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.22098315 |
74 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.21820412 |
75 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.20481483 |
76 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19977648 |
77 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19844577 |
78 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.19794933 |
79 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.19576431 |
80 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.19137279 |
81 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.16223979 |
82 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.16128146 |
83 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13622278 |
84 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.12682294 |
85 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.12667146 |
86 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11144885 |
87 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.11083322 |
88 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.10163208 |
89 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.09923226 |
90 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09635986 |
91 | SPI1_23127762_ChIP-Seq_K562_Human | 1.09330855 |
92 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.08898605 |
93 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.08898605 |
94 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.08030139 |
95 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.07975694 |
96 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.07746478 |
97 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.07531758 |
98 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.07171597 |
99 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.06749742 |
100 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06746970 |
101 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06333447 |
102 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.06150518 |
103 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06077010 |
104 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06034757 |
105 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.05750189 |
106 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.05718016 |
107 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.05157157 |
108 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05031127 |
109 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.04916690 |
110 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.04074107 |
111 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03651045 |
112 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.03008748 |
113 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.02730868 |
114 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02687210 |
115 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 1.02374563 |
116 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.02296724 |
117 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02201038 |
118 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.02190896 |
119 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.02167661 |
120 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.02130500 |
121 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02060218 |
122 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00400127 |
123 | KDM2B_26808549_Chip-Seq_K562_Human | 1.00342884 |
124 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.00122439 |
125 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.98782970 |
126 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.98527501 |
127 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.97991372 |
128 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.96374348 |
129 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.96248828 |
130 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96242593 |
131 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96074794 |
132 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95954992 |
133 | MAF_26560356_Chip-Seq_TH2_Human | 0.94973846 |
134 | MAF_26560356_Chip-Seq_TH1_Human | 0.94706130 |
135 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94439445 |
136 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.93635115 |
137 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.93054121 |
138 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92715291 |
139 | UTX_26944678_Chip-Seq_JUKART_Human | 0.92697830 |
140 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.92612471 |
141 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.91940266 |
142 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91869555 |
143 | ATF3_27146783_Chip-Seq_COLON_Human | 0.91869310 |
144 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.91547435 |
145 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.91482815 |
146 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.90234813 |
147 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89645588 |
148 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89239568 |
149 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.88910610 |
150 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.87584348 |
151 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87003997 |
152 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.86694135 |
153 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.86334954 |
154 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.86107917 |
155 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.85956128 |
156 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.85296025 |
157 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.84515365 |
158 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83956066 |
159 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.83890449 |
160 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.83839245 |
161 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.82746814 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 5.21372554 |
2 | MP0005365_abnormal_bile_salt | 3.81078181 |
3 | MP0003191_abnormal_cellular_cholesterol | 3.60369593 |
4 | MP0002877_abnormal_melanocyte_morpholog | 2.97339315 |
5 | MP0005360_urolithiasis | 2.86668457 |
6 | MP0005058_abnormal_lysosome_morphology | 2.62187390 |
7 | MP0002876_abnormal_thyroid_physiology | 2.52426801 |
8 | MP0009840_abnormal_foam_cell | 2.41369687 |
9 | MP0005085_abnormal_gallbladder_physiolo | 2.38173777 |
10 | MP0000013_abnormal_adipose_tissue | 2.32191459 |
11 | MP0003252_abnormal_bile_duct | 2.31222917 |
12 | MP0010329_abnormal_lipoprotein_level | 2.19766714 |
13 | MP0001968_abnormal_touch/_nociception | 2.19088594 |
14 | MP0010386_abnormal_urinary_bladder | 2.18778355 |
15 | MP0005083_abnormal_biliary_tract | 2.13678461 |
16 | MP0003724_increased_susceptibility_to | 2.09196330 |
17 | MP0008875_abnormal_xenobiotic_pharmacok | 2.07091330 |
18 | MP0009643_abnormal_urine_homeostasis | 1.99935063 |
19 | MP0008438_abnormal_cutaneous_collagen | 1.98232361 |
20 | MP0002837_dystrophic_cardiac_calcinosis | 1.90014528 |
21 | MP0002909_abnormal_adrenal_gland | 1.85024741 |
22 | MP0003806_abnormal_nucleotide_metabolis | 1.84529819 |
23 | MP0001666_abnormal_nutrient_absorption | 1.84430300 |
24 | MP0001958_emphysema | 1.84079905 |
25 | MP0003879_abnormal_hair_cell | 1.78744056 |
26 | MP0005332_abnormal_amino_acid | 1.78403269 |
27 | MP0003646_muscle_fatigue | 1.76581984 |
28 | MP0001501_abnormal_sleep_pattern | 1.76322144 |
29 | MP0000681_abnormal_thyroid_gland | 1.75235765 |
30 | MP0004043_abnormal_pH_regulation | 1.73831381 |
31 | MP0003195_calcinosis | 1.73460570 |
32 | MP0003011_delayed_dark_adaptation | 1.72741545 |
33 | MP0001944_abnormal_pancreas_morphology | 1.70961923 |
34 | MP0004019_abnormal_vitamin_homeostasis | 1.68746906 |
35 | MP0008872_abnormal_physiological_respon | 1.66353031 |
36 | MP0001873_stomach_inflammation | 1.63945747 |
37 | MP0003183_abnormal_peptide_metabolism | 1.63479829 |
38 | MP0003172_abnormal_lysosome_physiology | 1.57401990 |
39 | MP0002118_abnormal_lipid_homeostasis | 1.55307062 |
40 | MP0005220_abnormal_exocrine_pancreas | 1.54511583 |
41 | MP0001756_abnormal_urination | 1.53582166 |
42 | MP0005319_abnormal_enzyme/_coenzyme | 1.52523981 |
43 | MP0003045_fibrosis | 1.50751060 |
44 | MP0002693_abnormal_pancreas_physiology | 1.48821979 |
45 | MP0006054_spinal_hemorrhage | 1.48402297 |
46 | MP0001664_abnormal_digestion | 1.48128087 |
47 | MP0002138_abnormal_hepatobiliary_system | 1.47418256 |
48 | MP0004147_increased_porphyrin_level | 1.44208315 |
49 | MP0002078_abnormal_glucose_homeostasis | 1.44013667 |
50 | MP0003300_gastrointestinal_ulcer | 1.43826555 |
51 | MP0001661_extended_life_span | 1.38642937 |
52 | MP0009780_abnormal_chondrocyte_physiolo | 1.38457501 |
53 | MP0000609_abnormal_liver_physiology | 1.37348449 |
54 | MP0005646_abnormal_pituitary_gland | 1.36961109 |
55 | MP0005670_abnormal_white_adipose | 1.35880269 |
56 | MP0000003_abnormal_adipose_tissue | 1.32490013 |
57 | MP0002736_abnormal_nociception_after | 1.30446410 |
58 | MP0002653_abnormal_ependyma_morphology | 1.29296115 |
59 | MP0008775_abnormal_heart_ventricle | 1.27973461 |
60 | MP0009333_abnormal_splenocyte_physiolog | 1.23838985 |
61 | MP0003329_amyloid_beta_deposits | 1.23600905 |
62 | MP0002249_abnormal_larynx_morphology | 1.21481018 |
63 | MP0003656_abnormal_erythrocyte_physiolo | 1.19392797 |
64 | MP0002090_abnormal_vision | 1.18787520 |
65 | MP0002733_abnormal_thermal_nociception | 1.17929936 |
66 | MP0010368_abnormal_lymphatic_system | 1.17085876 |
67 | MP0000604_amyloidosis | 1.15269628 |
68 | MP0004130_abnormal_muscle_cell | 1.15109431 |
69 | MP0005375_adipose_tissue_phenotype | 1.12469007 |
70 | MP0001765_abnormal_ion_homeostasis | 1.12140807 |
71 | MP0005451_abnormal_body_composition | 1.12065638 |
72 | MP0003705_abnormal_hypodermis_morpholog | 1.11834812 |
73 | MP0002933_joint_inflammation | 1.11111011 |
74 | MP0002064_seizures | 1.10824538 |
75 | MP0005636_abnormal_mineral_homeostasis | 1.09870124 |
76 | MP0000685_abnormal_immune_system | 1.08821274 |
77 | MP0002971_abnormal_brown_adipose | 1.08315292 |
78 | MP0009745_abnormal_behavioral_response | 1.06583063 |
79 | MP0001970_abnormal_pain_threshold | 1.06096347 |
80 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.05457777 |
81 | MP0004885_abnormal_endolymph | 1.05416238 |
82 | MP0001533_abnormal_skeleton_physiology | 1.04521836 |
83 | MP0002148_abnormal_hypersensitivity_rea | 1.04413215 |
84 | MP0003075_altered_response_to | 1.04335113 |
85 | MP0005666_abnormal_adipose_tissue | 1.02942448 |
86 | MP0005000_abnormal_immune_tolerance | 1.01938959 |
87 | MP0009278_abnormal_bone_marrow | 1.01043756 |
88 | MP0001986_abnormal_taste_sensitivity | 1.00937271 |
89 | MP0001502_abnormal_circadian_rhythm | 0.99692292 |
90 | MP0010155_abnormal_intestine_physiology | 0.99638869 |
91 | MP0008469_abnormal_protein_level | 0.97990143 |
92 | MP0000230_abnormal_systemic_arterial | 0.97968749 |
93 | MP0008874_decreased_physiological_sensi | 0.97760422 |
94 | MP0002163_abnormal_gland_morphology | 0.96913591 |
95 | MP0009764_decreased_sensitivity_to | 0.95908863 |
96 | MP0004145_abnormal_muscle_electrophysio | 0.95206936 |
97 | MP0005410_abnormal_fertilization | 0.94997679 |
98 | MP0002822_catalepsy | 0.94491220 |
99 | MP0002136_abnormal_kidney_physiology | 0.94427451 |
100 | MP0002332_abnormal_exercise_endurance | 0.94048401 |
101 | MP0003866_abnormal_defecation | 0.93814352 |
102 | MP0004510_myositis | 0.92971324 |
103 | MP0003279_aneurysm | 0.92634178 |
104 | MP0000598_abnormal_liver_morphology | 0.92027729 |
105 | MP0005535_abnormal_body_temperature | 0.91893898 |
106 | MP0003436_decreased_susceptibility_to | 0.91111853 |
107 | MP0004264_abnormal_extraembryonic_tissu | 0.91074817 |
108 | MP0001764_abnormal_homeostasis | 0.90707803 |
109 | MP0003137_abnormal_impulse_conducting | 0.90486286 |
110 | MP0003283_abnormal_digestive_organ | 0.89707095 |
111 | MP0005671_abnormal_response_to | 0.89407185 |
112 | MP0003186_abnormal_redox_activity | 0.88681068 |
113 | MP0000538_abnormal_urinary_bladder | 0.87932375 |
114 | MP0000751_myopathy | 0.87708281 |
115 | MP0005025_abnormal_response_to | 0.87532808 |
116 | MP0002723_abnormal_immune_serum | 0.87333729 |
117 | MP0001800_abnormal_humoral_immune | 0.86757116 |
118 | MP0008961_abnormal_basal_metabolism | 0.85327118 |
119 | MP0003638_abnormal_response/metabolism_ | 0.85234397 |
120 | MP0009642_abnormal_blood_homeostasis | 0.85025510 |
121 | MP0001663_abnormal_digestive_system | 0.84950147 |
122 | MP0005448_abnormal_energy_balance | 0.84880980 |
123 | MP0005464_abnormal_platelet_physiology | 0.83416649 |
124 | MP0000015_abnormal_ear_pigmentation | 0.83261616 |
125 | MP0005310_abnormal_salivary_gland | 0.82958126 |
126 | MP0006276_abnormal_autonomic_nervous | 0.82229244 |
127 | MP0002928_abnormal_bile_duct | 0.82166610 |
128 | MP0003953_abnormal_hormone_level | 0.81311142 |
129 | MP0005387_immune_system_phenotype | 0.80861629 |
130 | MP0001790_abnormal_immune_system | 0.80861629 |
131 | MP0000747_muscle_weakness | 0.79941251 |
132 | MP0006036_abnormal_mitochondrial_physio | 0.79333977 |
133 | MP0002896_abnormal_bone_mineralization | 0.79057461 |
134 | MP0006082_CNS_inflammation | 0.78085761 |
135 | MP0001542_abnormal_bone_strength | 0.77975584 |
136 | MP0005551_abnormal_eye_electrophysiolog | 0.77017706 |
137 | MP0001270_distended_abdomen | 0.76012227 |
138 | MP0005275_abnormal_skin_tensile | 0.75284887 |
139 | MP0005334_abnormal_fat_pad | 0.73766845 |
140 | MP0005330_cardiomyopathy | 0.73421463 |
141 | MP0000249_abnormal_blood_vessel | 0.73117294 |
142 | MP0004782_abnormal_surfactant_physiolog | 0.72465992 |
143 | MP0004036_abnormal_muscle_relaxation | 0.71011357 |
144 | MP0004185_abnormal_adipocyte_glucose | 0.69812013 |
145 | MP0004233_abnormal_muscle_weight | 0.69746563 |
146 | MP0000343_altered_response_to | 0.68418686 |
147 | MP0002269_muscular_atrophy | 0.68344803 |
148 | MP0010030_abnormal_orbit_morphology | 0.67412030 |
149 | MP0000678_abnormal_parathyroid_gland | 0.66974354 |
150 | MP0001845_abnormal_inflammatory_respons | 0.66662265 |
151 | MP0000749_muscle_degeneration | 0.66593647 |
152 | MP0002998_abnormal_bone_remodeling | 0.66102206 |
153 | MP0004087_abnormal_muscle_fiber | 0.65825361 |
154 | MP0000465_gastrointestinal_hemorrhage | 0.64123651 |
155 | MP0004272_abnormal_basement_membrane | 0.63876230 |
Rank | Gene Set | Z-score |
---|---|---|
1 | J-shaped sella turcica (HP:0002680) | 4.59197736 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.19729612 |
3 | Hypoglycemic coma (HP:0001325) | 4.13434841 |
4 | Dysostosis multiplex (HP:0000943) | 3.71783896 |
5 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.55400835 |
6 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.52531316 |
7 | Ketoacidosis (HP:0001993) | 3.50766681 |
8 | Gout (HP:0001997) | 3.44415891 |
9 | Ketosis (HP:0001946) | 3.41948875 |
10 | Facial diplegia (HP:0001349) | 3.40677662 |
11 | Generalized aminoaciduria (HP:0002909) | 3.40626516 |
12 | Systemic lupus erythematosus (HP:0002725) | 3.37851109 |
13 | Vacuolated lymphocytes (HP:0001922) | 3.36451472 |
14 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.30355371 |
15 | Mucopolysacchariduria (HP:0008155) | 3.30355371 |
16 | Hypoglycemic seizures (HP:0002173) | 3.14982223 |
17 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.12195250 |
18 | Abnormality of the intrinsic pathway (HP:0010989) | 3.11678432 |
19 | Deep venous thrombosis (HP:0002625) | 3.06822812 |
20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.02139447 |
21 | Clumsiness (HP:0002312) | 2.98573282 |
22 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.97854883 |
23 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.97854883 |
24 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.97854883 |
25 | Abnormal pancreas size (HP:0012094) | 2.97029484 |
26 | Abnormality of purine metabolism (HP:0004352) | 2.86890268 |
27 | Increased cerebral lipofuscin (HP:0011813) | 2.86368597 |
28 | Late onset (HP:0003584) | 2.86102482 |
29 | Complement deficiency (HP:0004431) | 2.85210894 |
30 | Hydroxyprolinuria (HP:0003080) | 2.82006034 |
31 | Abnormality of proline metabolism (HP:0010907) | 2.82006034 |
32 | Mesangial abnormality (HP:0001966) | 2.78553302 |
33 | Xanthomatosis (HP:0000991) | 2.77554112 |
34 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.75020244 |
35 | Retinal atrophy (HP:0001105) | 2.72832393 |
36 | Ragged-red muscle fibers (HP:0003200) | 2.68152947 |
37 | Intrahepatic cholestasis (HP:0001406) | 2.67000753 |
38 | Stridor (HP:0010307) | 2.62592008 |
39 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.59308422 |
40 | Visual hallucinations (HP:0002367) | 2.59129355 |
41 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.58332250 |
42 | Abnormality of the common coagulation pathway (HP:0010990) | 2.56289015 |
43 | Congenital stationary night blindness (HP:0007642) | 2.55356270 |
44 | Tongue fasciculations (HP:0001308) | 2.53786204 |
45 | Hyperventilation (HP:0002883) | 2.53682495 |
46 | Hyperthyroidism (HP:0000836) | 2.48630103 |
47 | Polycythemia (HP:0001901) | 2.48467121 |
48 | Cerebral palsy (HP:0100021) | 2.47775048 |
49 | Increased purine levels (HP:0004368) | 2.45129447 |
50 | Hyperuricemia (HP:0002149) | 2.45129447 |
51 | Hyperglycemia (HP:0003074) | 2.44754593 |
52 | Skin nodule (HP:0200036) | 2.44605206 |
53 | Ileus (HP:0002595) | 2.44573406 |
54 | Symptomatic seizures (HP:0011145) | 2.42555889 |
55 | Mitral stenosis (HP:0001718) | 2.37177973 |
56 | Sensorimotor neuropathy (HP:0007141) | 2.36326154 |
57 | Hypoalphalipoproteinemia (HP:0003233) | 2.32356143 |
58 | Asymmetric septal hypertrophy (HP:0001670) | 2.31468437 |
59 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.30558970 |
60 | Vascular calcification (HP:0004934) | 2.29307545 |
61 | Pigmentary retinal degeneration (HP:0001146) | 2.26462158 |
62 | Truncus arteriosus (HP:0001660) | 2.26034660 |
63 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.25450538 |
64 | Dicarboxylic aciduria (HP:0003215) | 2.25450538 |
65 | Severe muscular hypotonia (HP:0006829) | 2.21670526 |
66 | Thin bony cortex (HP:0002753) | 2.20073225 |
67 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.18606543 |
68 | Muscle fibrillation (HP:0010546) | 2.18592586 |
69 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.18256214 |
70 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.18256214 |
71 | Abnormality of glycolipid metabolism (HP:0010969) | 2.18256214 |
72 | Cardiovascular calcification (HP:0011915) | 2.18232864 |
73 | Type II lissencephaly (HP:0007260) | 2.16988009 |
74 | Anomalous pulmonary venous return (HP:0010772) | 2.16252382 |
75 | Amelogenesis imperfecta (HP:0000705) | 2.15256126 |
76 | Hyperlipoproteinemia (HP:0010980) | 2.13878978 |
77 | Glomerulonephritis (HP:0000099) | 2.13783449 |
78 | Hyperactive renin-angiotensin system (HP:0000841) | 2.12784512 |
79 | Insulin resistance (HP:0000855) | 2.12764797 |
80 | Hyperammonemia (HP:0001987) | 2.12712920 |
81 | Progressive neurologic deterioration (HP:0002344) | 2.12017543 |
82 | Congenital sensorineural hearing impairment (HP:0008527) | 2.11955148 |
83 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.09992060 |
84 | Progressive microcephaly (HP:0000253) | 2.09508200 |
85 | Myoglobinuria (HP:0002913) | 2.06458570 |
86 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.06422861 |
87 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.06422861 |
88 | Abnormality of nucleobase metabolism (HP:0010932) | 2.03915870 |
89 | Broad metatarsal (HP:0001783) | 2.03871967 |
90 | Myositis (HP:0100614) | 2.03035935 |
91 | Severe visual impairment (HP:0001141) | 2.00729090 |
92 | Ovoid vertebral bodies (HP:0003300) | 2.00560230 |
93 | Abnormality of alanine metabolism (HP:0010916) | 1.99054311 |
94 | Hyperalaninemia (HP:0003348) | 1.99054311 |
95 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.99054311 |
96 | Prolonged QT interval (HP:0001657) | 1.99042366 |
97 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.97933915 |
98 | Alkalosis (HP:0001948) | 1.96883535 |
99 | Abnormal EKG (HP:0003115) | 1.96498099 |
100 | Cardiomegaly (HP:0001640) | 1.96232326 |
101 | Syncope (HP:0001279) | 1.96146065 |
102 | Beaking of vertebral bodies (HP:0004568) | 1.96046594 |
103 | Hypokalemia (HP:0002900) | 1.95380003 |
104 | Spondylolisthesis (HP:0003302) | 1.94638935 |
105 | Abnormality of complement system (HP:0005339) | 1.94147428 |
106 | Large for gestational age (HP:0001520) | 1.91795583 |
107 | Irritability (HP:0000737) | 1.91479740 |
108 | Nonimmune hydrops fetalis (HP:0001790) | 1.91029479 |
109 | Protuberant abdomen (HP:0001538) | 1.89511989 |
110 | Hand muscle atrophy (HP:0009130) | 1.88678988 |
111 | Microretrognathia (HP:0000308) | 1.87958969 |
112 | Cerebral aneurysm (HP:0004944) | 1.87837440 |
113 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.86947437 |
114 | Hypolipoproteinemia (HP:0010981) | 1.84670414 |
115 | Hyperglycinuria (HP:0003108) | 1.84627491 |
116 | Acne (HP:0001061) | 1.84356664 |
117 | Aortic aneurysm (HP:0004942) | 1.83286159 |
118 | Nephritis (HP:0000123) | 1.83077245 |
119 | Infantile muscular hypotonia (HP:0008947) | 1.82807772 |
120 | Abnormality of the pulmonary veins (HP:0011718) | 1.82228807 |
121 | Generalized amyotrophy (HP:0003700) | 1.82049304 |
122 | Palpitations (HP:0001962) | 1.81913071 |
123 | Right ventricular cardiomyopathy (HP:0011663) | 1.81085454 |
124 | Fat malabsorption (HP:0002630) | 1.80343572 |
125 | Decreased circulating renin level (HP:0003351) | 1.79986095 |
126 | Abnormality of the odontoid process (HP:0003310) | 1.79897502 |
127 | Orchitis (HP:0100796) | 1.79713075 |
128 | Interstitial pulmonary disease (HP:0006530) | 1.79466804 |
129 | Axonal loss (HP:0003447) | 1.79417574 |
130 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.77515840 |
131 | Prolonged neonatal jaundice (HP:0006579) | 1.77463763 |
132 | Bulbar palsy (HP:0001283) | 1.77102017 |
133 | Joint stiffness (HP:0001387) | 1.75882692 |
134 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.74745879 |
135 | Decreased subcutaneous fat (HP:0001002) | 1.74360290 |
136 | Deformed sella turcica (HP:0002681) | 1.74276771 |
137 | Difficulty walking (HP:0002355) | 1.74096788 |
138 | Proximal tubulopathy (HP:0000114) | 1.74019688 |
139 | EMG: myopathic abnormalities (HP:0003458) | 1.73909636 |
140 | Abdominal distention (HP:0003270) | 1.73203843 |
141 | Ventricular fibrillation (HP:0001663) | 1.72707265 |
142 | Abnormality of the aortic arch (HP:0012303) | 1.72533650 |
143 | Increased muscle lipid content (HP:0009058) | 1.72312541 |
144 | Metabolic acidosis (HP:0001942) | 1.72279980 |
145 | Hyperbilirubinemia (HP:0002904) | 1.71917796 |
146 | Upper limb amyotrophy (HP:0009129) | 1.70731968 |
147 | Distal upper limb amyotrophy (HP:0007149) | 1.70731968 |
148 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.70621379 |
149 | Opisthotonus (HP:0002179) | 1.69336854 |
150 | Dysautonomia (HP:0002459) | 1.68912021 |
151 | Genetic anticipation (HP:0003743) | 1.68643455 |
152 | Attenuation of retinal blood vessels (HP:0007843) | 1.65766592 |
153 | Hemorrhage of the eye (HP:0011885) | 1.65249733 |
154 | Pustule (HP:0200039) | 1.63658812 |
155 | Concave nail (HP:0001598) | 1.63545495 |
156 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.63110788 |
157 | Retinal dysplasia (HP:0007973) | 1.62456735 |
158 | Tented upper lip vermilion (HP:0010804) | 1.62372305 |
159 | Abnormality of dental color (HP:0011073) | 1.62224658 |
160 | Increased serum ferritin (HP:0003281) | 1.56722331 |
161 | Abnormal gallbladder physiology (HP:0012438) | 1.56358617 |
162 | Cholecystitis (HP:0001082) | 1.56358617 |
163 | Optic neuritis (HP:0100653) | 1.55895283 |
164 | Retrobulbar optic neuritis (HP:0100654) | 1.55895283 |
165 | Ventricular arrhythmia (HP:0004308) | 1.55892417 |
166 | Hypoplasia of the odontoid process (HP:0003311) | 1.55546806 |
167 | Supraventricular tachycardia (HP:0004755) | 1.55303691 |
168 | Hypertensive crisis (HP:0100735) | 1.55118286 |
169 | Neonatal respiratory distress (HP:0002643) | 1.54989333 |
170 | Albinism (HP:0001022) | 1.53066315 |
171 | Cystic liver disease (HP:0006706) | 1.52404199 |
172 | Abnormality of the sella turcica (HP:0002679) | 1.52082801 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 5.48285059 |
2 | TRIB3 | 3.60703588 |
3 | BCKDK | 3.27485173 |
4 | EEF2K | 2.61744907 |
5 | PKN2 | 2.42884657 |
6 | GRK6 | 2.35469771 |
7 | MAP2K3 | 2.32890227 |
8 | TGFBR2 | 2.32264347 |
9 | MAPK15 | 2.31710111 |
10 | MAPKAPK3 | 2.25656469 |
11 | SIK1 | 2.23066425 |
12 | PRKD3 | 2.14326896 |
13 | PTK6 | 2.11170311 |
14 | MAP3K3 | 2.04883530 |
15 | INSRR | 2.01567464 |
16 | MUSK | 1.94191283 |
17 | ZAP70 | 1.93870002 |
18 | ADRBK2 | 1.93412376 |
19 | MAP3K11 | 1.88561512 |
20 | TESK2 | 1.87773784 |
21 | BLK | 1.86388455 |
22 | GRK5 | 1.79262640 |
23 | FLT3 | 1.72300059 |
24 | WNK4 | 1.71483328 |
25 | TBK1 | 1.70846646 |
26 | TNK2 | 1.62385925 |
27 | DAPK2 | 1.61505708 |
28 | MAP4K1 | 1.59076542 |
29 | LMTK2 | 1.58210426 |
30 | MAP4K2 | 1.53434810 |
31 | FGFR4 | 1.51419722 |
32 | EPHA2 | 1.36659325 |
33 | TAOK3 | 1.33867028 |
34 | PASK | 1.33288886 |
35 | MAP3K2 | 1.32872648 |
36 | ACVR1B | 1.30895514 |
37 | TAOK1 | 1.27207212 |
38 | ADRBK1 | 1.25326415 |
39 | DYRK1B | 1.23149318 |
40 | IKBKB | 1.22968703 |
41 | MYLK | 1.22336743 |
42 | TAOK2 | 1.21994704 |
43 | PRKCH | 1.21118055 |
44 | GRK1 | 1.20805493 |
45 | PIK3CG | 1.20696250 |
46 | NEK9 | 1.20470361 |
47 | LIMK1 | 1.16820406 |
48 | PIM2 | 1.13538795 |
49 | IRAK2 | 1.12503244 |
50 | WNK3 | 1.11801825 |
51 | CAMKK1 | 1.10665125 |
52 | IRAK1 | 1.09757856 |
53 | ARAF | 1.08427025 |
54 | KIT | 1.05639874 |
55 | MAP3K1 | 1.05184429 |
56 | TTN | 1.04725657 |
57 | TXK | 1.04271986 |
58 | NTRK3 | 1.03613224 |
59 | HIPK2 | 1.00851594 |
60 | PINK1 | 1.00657961 |
61 | PRKD2 | 0.99743929 |
62 | NME2 | 0.98596069 |
63 | PDK2 | 0.98594656 |
64 | KDR | 0.98129265 |
65 | BMX | 0.98107461 |
66 | PDGFRA | 0.97922893 |
67 | PTK2B | 0.95891491 |
68 | CAMKK2 | 0.95251810 |
69 | IRAK4 | 0.91567622 |
70 | DAPK1 | 0.90083275 |
71 | PTK2 | 0.89516796 |
72 | RPS6KB2 | 0.88436253 |
73 | MAPK12 | 0.88183019 |
74 | LRRK2 | 0.86029974 |
75 | RIPK4 | 0.85133485 |
76 | PRKCI | 0.82830475 |
77 | TRPM7 | 0.82734889 |
78 | PRPF4B | 0.82335778 |
79 | RIPK1 | 0.79807667 |
80 | MAPKAPK5 | 0.78830367 |
81 | MATK | 0.77535793 |
82 | EPHB1 | 0.75291124 |
83 | JAK1 | 0.75196937 |
84 | BTK | 0.75160446 |
85 | IRAK3 | 0.74454461 |
86 | STK38L | 0.74242147 |
87 | FES | 0.71707090 |
88 | SYK | 0.71332755 |
89 | JAK2 | 0.69284217 |
90 | ITK | 0.69092144 |
91 | TYK2 | 0.68881179 |
92 | PRKD1 | 0.68616235 |
93 | RPS6KA6 | 0.68487805 |
94 | RET | 0.67634532 |
95 | MAP2K2 | 0.64755922 |
96 | TIE1 | 0.64290130 |
97 | MAP3K7 | 0.64168284 |
98 | ABL2 | 0.64163688 |
99 | SMG1 | 0.63194901 |
100 | TLK1 | 0.63095938 |
101 | MARK2 | 0.62291479 |
102 | SIK2 | 0.61877179 |
103 | STK38 | 0.60267228 |
104 | MAP3K5 | 0.60187593 |
105 | MAPK11 | 0.60132666 |
106 | PDPK1 | 0.59953711 |
107 | VRK2 | 0.57852222 |
108 | PRKG2 | 0.57431703 |
109 | EPHA3 | 0.57278205 |
110 | SCYL2 | 0.56750920 |
111 | CAMK2G | 0.56294392 |
112 | NTRK1 | 0.55910514 |
113 | RPS6KA2 | 0.55642584 |
114 | CSK | 0.55205860 |
115 | PRKAA1 | 0.54890058 |
116 | IKBKE | 0.54668309 |
117 | CAMK2B | 0.54468723 |
118 | FER | 0.52726964 |
119 | CAMK2D | 0.51638738 |
120 | MTOR | 0.50261798 |
121 | MAP2K6 | 0.50185043 |
122 | JAK3 | 0.49222904 |
123 | GRK7 | 0.48631459 |
124 | RPS6KC1 | 0.48417316 |
125 | RPS6KL1 | 0.48417316 |
126 | PIK3CA | 0.48053961 |
127 | PDK1 | 0.47520419 |
128 | EIF2AK1 | 0.47428870 |
129 | IGF1R | 0.47260107 |
130 | TESK1 | 0.46572639 |
131 | STK10 | 0.46379413 |
132 | PAK4 | 0.45609770 |
133 | PAK3 | 0.45386351 |
134 | MAPK13 | 0.45039814 |
135 | KSR2 | 0.44546348 |
136 | PAK6 | 0.42859751 |
137 | CDC42BPA | 0.42436712 |
138 | PRKAA2 | 0.42256279 |
139 | PHKG1 | 0.42241737 |
140 | PHKG2 | 0.42241737 |
141 | MAPKAPK2 | 0.41044665 |
142 | MAP2K1 | 0.40975771 |
143 | FRK | 0.39707343 |
144 | DAPK3 | 0.39053978 |
145 | MAPK7 | 0.39034529 |
146 | MAP3K6 | 0.38750071 |
147 | CAMK1 | 0.38450315 |
148 | MST1R | 0.37248922 |
149 | ILK | 0.36321064 |
150 | FGFR3 | 0.34220445 |
151 | PDGFRB | 0.33174339 |
152 | GSK3A | 0.30745150 |
153 | PAK2 | 0.28762624 |
154 | TGFBR1 | 0.27234238 |
155 | MAP3K10 | 0.25716722 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.18886458 |
2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.29174809 |
3 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.93806573 |
4 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.43594548 |
5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.38752534 |
6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.32324449 |
7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.29484019 |
8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.20939257 |
9 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.15590136 |
10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.14121095 |
11 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.07735783 |
12 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.06301205 |
13 | Lysosome_Homo sapiens_hsa04142 | 1.99364767 |
14 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.96426930 |
15 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.92700652 |
16 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.90445783 |
17 | Protein export_Homo sapiens_hsa03060 | 1.90187459 |
18 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.85188986 |
19 | Other glycan degradation_Homo sapiens_hsa00511 | 1.84013207 |
20 | Peroxisome_Homo sapiens_hsa04146 | 1.76513866 |
21 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.75855595 |
22 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.73354059 |
23 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.69123796 |
24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.68704866 |
25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.59447967 |
26 | ABC transporters_Homo sapiens_hsa02010 | 1.55419842 |
27 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.53714834 |
28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.53258307 |
29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.52182579 |
30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.51190849 |
31 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.46515503 |
32 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.44837669 |
33 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.40113115 |
34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.38740945 |
35 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.38162350 |
36 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.34948420 |
37 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.32119246 |
38 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.30207181 |
39 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.26113847 |
40 | Histidine metabolism_Homo sapiens_hsa00340 | 1.25148953 |
41 | Galactose metabolism_Homo sapiens_hsa00052 | 1.24040734 |
42 | Insulin resistance_Homo sapiens_hsa04931 | 1.22455131 |
43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20260575 |
44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.19552593 |
45 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.17256887 |
46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.15216278 |
47 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.13506340 |
48 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.10010347 |
49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.10005994 |
50 | Salivary secretion_Homo sapiens_hsa04970 | 1.08186554 |
51 | Bile secretion_Homo sapiens_hsa04976 | 1.07205563 |
52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.03810584 |
53 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.03298684 |
54 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.03026444 |
55 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.02644335 |
56 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.01750780 |
57 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.00516681 |
58 | Prion diseases_Homo sapiens_hsa05020 | 0.98921535 |
59 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.96359268 |
60 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.96034558 |
61 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.94352073 |
62 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.92117463 |
63 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.92025743 |
64 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.91462382 |
65 | Carbon metabolism_Homo sapiens_hsa01200 | 0.89975719 |
66 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.88784532 |
67 | Morphine addiction_Homo sapiens_hsa05032 | 0.88249971 |
68 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.87643148 |
69 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.82743374 |
70 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.82196878 |
71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.80946725 |
72 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.79109633 |
73 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.78424975 |
74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.77967669 |
75 | Circadian entrainment_Homo sapiens_hsa04713 | 0.77249379 |
76 | Phototransduction_Homo sapiens_hsa04744 | 0.76694007 |
77 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.74235138 |
78 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.74096576 |
79 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.73682373 |
80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73657463 |
81 | Mineral absorption_Homo sapiens_hsa04978 | 0.73540594 |
82 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.72460853 |
83 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70549393 |
84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70376566 |
85 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.69349344 |
86 | Insulin secretion_Homo sapiens_hsa04911 | 0.69282159 |
87 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.66218176 |
88 | Sulfur relay system_Homo sapiens_hsa04122 | 0.65531419 |
89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64151643 |
90 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.63589494 |
91 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.63191491 |
92 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.62796186 |
93 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.62702267 |
94 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.60634457 |
95 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.59544582 |
96 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.59469850 |
97 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.59242014 |
98 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.58800613 |
99 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.56858089 |
100 | Retinol metabolism_Homo sapiens_hsa00830 | 0.56325214 |
101 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.55836980 |
102 | Legionellosis_Homo sapiens_hsa05134 | 0.53856449 |
103 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53793569 |
104 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.51660483 |
105 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50796714 |
106 | Pertussis_Homo sapiens_hsa05133 | 0.50674042 |
107 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.50460413 |
108 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.50294673 |
109 | GABAergic synapse_Homo sapiens_hsa04727 | 0.48634061 |
110 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.47231319 |
111 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.45688146 |
112 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45176871 |
113 | Olfactory transduction_Homo sapiens_hsa04740 | 0.44985953 |
114 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44539802 |
115 | Taste transduction_Homo sapiens_hsa04742 | 0.44192808 |
116 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.44145808 |
117 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.44049467 |
118 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.42332251 |
119 | Leishmaniasis_Homo sapiens_hsa05140 | 0.41259379 |
120 | Hepatitis C_Homo sapiens_hsa05160 | 0.40717230 |
121 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.40384464 |
122 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39825696 |
123 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.39642109 |
124 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.38160188 |
125 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.36843992 |
126 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.36709323 |
127 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.35493422 |
128 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.35492262 |
129 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34102207 |
130 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.33922888 |
131 | Lysine degradation_Homo sapiens_hsa00310 | 0.33164776 |
132 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.32726322 |
133 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.32312072 |
134 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.32200985 |
135 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32014475 |
136 | Amoebiasis_Homo sapiens_hsa05146 | 0.31992985 |
137 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.31680697 |
138 | Phagosome_Homo sapiens_hsa04145 | 0.31486670 |
139 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.30428723 |
140 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.28308415 |
141 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.26939326 |